The result is quite significant in that reduced CHCHD2 mRNA could be a potential biomarker for early PD, when clinical diagnosis is most difficult due to overlapping clinical phenotypes in related diseases.
← all excerpts
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
1
—
—